Clinical Trials Browser

Phase 3 × Carcinoma, Renal Cell × Granulocyte-Macrophage Colony-Stimulating Factor × Clear all

NCT01265901 2017-10-12

IMA901 in Patients Receiving Sunitinib for Advanced/Metastatic Renal Cell Carcinoma

Phase 3 Completed

Carcinoma, Renal Cell